Optimised Dosing of Antibiotics - Understanding PKPD, Clinical Breakpoints, and Therapeutic Drug Monitoring

Event Description

12 - 13 March 2026

In the field of antimicrobial therapy, achieving optimal dosing of antibiotics is essential to ensure effective treatment outcomes while minimizing the risk of adverse effects and antimicrobial resistance. This course aims to provide participants with a comprehensive understanding of pharmacokinetics/pharmacodynamics (PK/PD) principles, strategies for setting clinical breakpoints, individualized dosing approaches, and the role of therapeutic drug monitoring (TDM) in optimizing antibiotic therapy.

Intended audience:  

Participants of the ESCMID AMS Certificate program, specialists in infectious diseases, intensive care specialists, clinical microbiologists, pharmacologists and pharmacists.


This course presents and summarises currently available knowledge on PK/PD of commonly used antibiotics, strategies for setting clinical breakpoints, individualised dosing, and therapeutic drug monitoring. The aim is to provide participants with insights that can be used to optimise antibiotic therapy for different patient groups, infection sites and pathogens.

Course coordinator: 

Thomas Tängdén, Sweden


ESCMID PK/PD of Anti-Infectives Study Group (EPASG)


Course organisers will monitor attendance. Only participants attending live sessions will be able to receive the certification.

Registration details: 

This course is part of the AMS Certificate Programme, but has some spaces open to registrations outside of the programme.

Registration fees include full access to the online course.  


Attendance Grant application

Attendance grant application is not applicable

Registration Fees



ESCMID Members

EUR 150

Non-ESCMID Members

EUR 200

ESCMID Young Scientist Members

EUR 50


EUR 20